Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holly Janes

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
Biostatistics (Oxford, England)|April 30, 2013
Letter to the editorHolly Janes
Biostatistics (Oxford, England)|January 24, 2006
The optimal ratio of cases to controls for estimating the classification accuracy of a biomarkerHolly Janes, Margaret Pepe
American Journal of Epidemiology|March 26, 2013
Re: "Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance: the Tehran Lipid and Glucose Study"Holly Janes, Margaret Pepe
Current Opinion in HIV and AIDS|September 15, 2023
Control groups for HIV prevention efficacy trials: what does the future hold?Holly Janes, Susan Buchbinder
International Journal of Epidemiology|May 17, 2011
Commentary: Reporting standards are needed for evaluations of risk reclassificationMargaret S Pepe, Holly Janes
Biostatistics (Oxford, England)|November 7, 2006
Insights into latent class analysis of diagnostic test performanceMargaret Sullivan Pepe, Holly Janes
American Journal of Epidemiology|May 15, 2008
Adjusting for covariates in studies of diagnostic, screening, or prognostic markers: an old concept in a new settingHolly Janes, Margaret S Pepe
Biometrika|July 24, 2012
Adjusting for covariate effects on classification accuracy using the covariate-adjusted receiver operating characteristic curveHolly Janes, Margaret S Pepe
Biometrics|May 16, 2007
Matching in studies of classification accuracy: implications for analysis, efficiency, and assessment of incremental valueHolly Janes, Margaret S Pepe
Statistics in Medicine|November 21, 2017
First things first: risk model performance metrics should reflect the clinical applicationKathleen F Kerr, Holly Janes
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
Biostatistics (Oxford, England)|April 30, 2013
Letter to the editorHolly Janes
Biostatistics (Oxford, England)|January 24, 2006
The optimal ratio of cases to controls for estimating the classification accuracy of a biomarkerHolly Janes, Margaret Pepe
American Journal of Epidemiology|March 26, 2013
Re: "Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance: the Tehran Lipid and Glucose Study"Holly Janes, Margaret Pepe
Current Opinion in HIV and AIDS|September 15, 2023
Control groups for HIV prevention efficacy trials: what does the future hold?Holly Janes, Susan Buchbinder
International Journal of Epidemiology|May 17, 2011
Commentary: Reporting standards are needed for evaluations of risk reclassificationMargaret S Pepe, Holly Janes
Biostatistics (Oxford, England)|November 7, 2006
Insights into latent class analysis of diagnostic test performanceMargaret Sullivan Pepe, Holly Janes
American Journal of Epidemiology|May 15, 2008
Adjusting for covariates in studies of diagnostic, screening, or prognostic markers: an old concept in a new settingHolly Janes, Margaret S Pepe
Biometrika|July 24, 2012
Adjusting for covariate effects on classification accuracy using the covariate-adjusted receiver operating characteristic curveHolly Janes, Margaret S Pepe
Biometrics|May 16, 2007
Matching in studies of classification accuracy: implications for analysis, efficiency, and assessment of incremental valueHolly Janes, Margaret S Pepe
Statistics in Medicine|November 21, 2017
First things first: risk model performance metrics should reflect the clinical applicationKathleen F Kerr, Holly Janes
Pageof 14